Behavioral & Integrative Treatment Development Program (R34)
Grant Amounts: The National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAA) and the Office of Behavioral and Social Sciences Research (OBSSR) will provide a toal of $450,000 over and R34 3-year period. The purpose of this FOA for R34s is to encourage investigators to propose discrete well-defined projects that can be completed within three years. Projects of interest fall within the research domain of behavioral or integrated (e.g., behavioral and pharmacological) interventions targeting: (a) substance abuse (including comorbidities); (b) prevention of acquisition or transmission of HIV infection among individuals in substance abuse treatment; (c) promotion of adherence to substance abuse treatment, HIV and addiction medications; and (d) chronic pain. Specific examples include, but are not limited to studies focusing on: (1) Stage I intervention generation; (2) Stage I pilot or feasibility and both should include the development of putative moderators, mediators, and change mechanisms. (3) Stage I studies to generate or refine substance abuse treatment or adherence interventions for use in primary care; (4) Stage I research to boost effects and increase implementability of interventions with creative use of technology.
Companion funding opportunities are: PA-13-077, R01 Research Project Grant and PA-13-079, R03 Small Grant Program
National Institute on Drug Abuse US Department of Health and Human Services Public Health Service National Institutes of Health National Institute on Alcohol Abuse and Alcoholism
City Agencies Colleges/Universities Commercial Organizations County Agencies International Agencies IRS 501 (c)(3) Organizations Minority Owned Organizations Nonprofit Organizations Public Health Departments/Social Services Departments Religious Organizations Schools State Agencies Tribal Organizations
Award Amount Notes
The number of awards is contingent upon NIH appropriations, and the submission of a sufficient number of meritorious applications.
Direct costs are limited to $450,000 over an R34 3-year period, with no more than $225,000 in direct costs allowed in any single year.
Lisa Onken Ph.D. Chief, Behav & Integra Treat Branch Assoc Dir for TreatmentDiv of Clin Neuro & Behav Resch NIH NIDA 6001 Executive Blvd Room 3172 MSC 9593 Bethesda, MD , 208929593 Phone: (301) 443-2235
Behavioral Research Clinical Trials Drug Abuse Education and Prevention HIV/AIDS Prevention Substance Abuse Treatment and Counseling
Health Professionals Physicians Researchers
Applications must be submitted electronically following the instructions described in the SF 424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically.
Important reminders: All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF 424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH.
The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management (SAM). Additional information may be found in the SF424 (R&R) Application Guide.
See more tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review, NIH. Applications that are incomplete will not be reviewed.
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.